DRREDDY vs HDFCLIFE: Stock Comparison
HDFC LIFE INS CO is the larger company by market capitalisation. DR. REDDY S LABORATORIES shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 8; HDFCLIFE leads 1 of 9
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | HDFCLIFE |
|---|---|---|
| Sector | Healthcare | Financial Services |
| Industry | Pharmaceuticals | Life Insurance |
Price
| Metric | DRREDDY | HDFCLIFE |
|---|---|---|
| Live Price | ₹1,197 | ₹556.65 |
| Day Change | 1.44% | 2.23% |
| Volume | 15.1 L | 27.13 L |
| 52-Week High | ₹1,414.9 | ₹788.5 |
| 52-Week Low | ₹1,101 | ₹508.7 |
| Distance from 52W High | -15.4% | -29.4% |
Valuation
| Metric | DRREDDY | HDFCLIFE |
|---|---|---|
| Market Cap | ₹99,752 Cr | ₹1.21 L Cr |
| P/E Ratio | 30.95x | 60.72x |
| P/B Ratio | 2.63x | 6.75x |
| EPS | ₹5.32 | ₹2.81 |
| Book Value | ₹458.03 | ₹81.7 |
| Dividend Yield | 0.67% | 0.38% |
Growth
| Metric | DRREDDY | HDFCLIFE |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | -17.7% |
| EPS Growth (TTM YoY) | -86.2% | 4.1% |
| Qtr Sales Growth | 57.69% | — |
| Qtr Profit Growth | 7.64% | — |
Profitability & Leverage
Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.| Metric | DRREDDY | HDFCLIFE |
|---|---|---|
| ROE | 10.87% | 10.77% |
| ROCE | 13.38% | — |
| Net Margin | 12.76% | 1.89% |
| Operating Margin | 17.07% | 1.99% |
| Debt to Equity | 0.16x | 0.17x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | HDFCLIFE |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | 50.54%▲ 0.33 pp |
| FII Holding | 32.07%▼ 1.01 pp | 19.27%▼ 3.25 pp |
| DII Holding | 31.74%▲ 1.02 pp | 20.19%▲ 2.94 pp |
| Public Holding | 9.35%▲ 0.02 pp | 9.98%▼ 0.02 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. REDDY S LABORATORIES and HDFC LIFE INS CO.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.